Weston, FL, United States of America

Parag Shah

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Parag Shah. Retrieved from https://idiyas.com/inventor/parag-shah-fbfa4snk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Parag Shah: Innovator in Osmotic Dosage Forms

Introduction

Parag Shah is a notable inventor based in Weston, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of osmotic dosage forms. His work focuses on improving treatment efficacy for various movement disorders.

Latest Patents

Parag Shah holds a patent for "Osmotic dosage forms comprising deutetrabenazine and methods of use thereof." This patent describes osmotic dosage forms containing deutetrabenazine, which are designed for the treatment of hyperkinetic movement disorders. When administered orally on a once-daily basis, these dosage forms provide a favorable pharmacokinetic profile for the active agent, indicating treatment efficacy over an extended period of time.

Career Highlights

Parag Shah is currently associated with Auspex Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of osmotic drug delivery systems.

Collaborations

Some of his notable coworkers include Mayank Joshi and Soumen Pattanayek, who contribute to the collaborative efforts at Auspex Pharmaceuticals, Inc.

Conclusion

Parag Shah's contributions to osmotic dosage forms and his innovative approach to treating movement disorders highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…